An approach to malignant mammary phyllodes tumors detection

被引:4
|
作者
Ilic, Ivan [1 ]
Randelovic, Pavle [2 ]
Ilic, Ratko [1 ]
Katic, Vuka [1 ]
Milentijevic, Maja [1 ]
Velickovic, Ljubinka [1 ]
Krstic, Miljan [1 ]
机构
[1] Fac Med, Inst Pathol, Nish, Serbia
[2] Fac Med, Inst Physiol, Nish, Serbia
关键词
phyllodes tumor; Ki-67antigen receptors; estrogen; receptors; progesterone; genes; erbB-2; mast cells; leucyl aminopeptidase; breast neoplasms; diagnosis; LOCAL RECURRENCE; BREAST-CANCER; C-KIT; EXPRESSION; ENDOTHELIN-1; RECEPTOR; THERAPY; LESIONS;
D O I
10.2298/VSP0904277I
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Aim. Mammary phyllodes tumors (MPT) are Uncommon Fibroepithelial (biphasic) neoplasms whose clinical behavior is difficult to predict on the basis of histological criteria only. They are divided into benign, borderline malignant and malignant groups. Sometimes it appears difficult to distinguish these tumors from other types of soft tissue sarcomas. Because of the relatively scant data on the role of biological markers in MPT histogenesis, we have decided to undertake the following study, trying to shed more light on the issue by investigating the following elements that make up NIPT: their histological patterns, biological behavior, enzymohistochemical, histochemical and immunohistochemical characteristics (ICH) together with the mast cell analysis. Methods. We examined the biopsy material of 35 NIPT in Our laboratory. Enzymohistochemistry was performed on frozen sections (method of Crowford, Nachlas and Seligman). The used methods were classical hematoxylin-eosin (H & E); histochemical Massontrichrome, Alcian-blue, Periodic acid Schiff and immunohistochemical LSAB2 method (DacoCytomation). Ki-67, c-kit, vimentin, estrogen receptor (F-R), progesterone receptor (PR) and Her-2 oncoprotein immunohistochemistry was performed on all tumors. Results. The patients were ranged per age from 30-62 years (mean 43.3 years, median 39 years). A total of 35 cases of MPT were included: 20 benign (57%), 6 borderline malignant (17%) and 9 malignant (26%). Twenty-two patients (62.8%) underwent: segmental mastectomy, while 13 (37.2%) had total mastectomies. Twenty-eight patients had negative surgical margins at original resection. The mean size of malignant MPT (7.8 cm) was larger than that of benign MPT (4.5 cm). Significant features of the malignant MPT were: stromal cellularity, stromal cellular atypism, high mitotic activity, atypic mitoses, stromal overgrowth, infiltrative tumor contour and heterologous stromal elements. Benign MPT showed strong enzymohistochemical Leucine Amino Peptidase (LAP) activity in both epithelial and stromal components while it was weak or absent in the epithelial parts of the malignant tumors, Acid mucopolysacharides were present in the stromal component of all types of these tumors. Benign MPT had a lower Ki-67 than did borderline malignant MPT (4 versus 28). Malignant MPT had a greater than 8-fold higher Ki-67 activity than did benign tumors (35 versus 4). Intracytoplasmatic c-kit expression was associated with a pathological diagnosis of malignant MPT, correlating with increasing grade (p < 0.05). In hypercellular stroma of borderline malignant and especially malignant forms of MPT, high activity of ER in mast cells was confirmed. Oncoprotein Her-2 activity, mostly in epithelial components, correlated with the degree of malignant progression of MPT (b < 0.05). Conclusion. Besides the well-known malignant features additional parameters have been found to be high Ki-67 and c-kit stromal expressions, and weak LAP activity in the epithelial part of malignant M-PT, as well as mast cells with a high expression of ER.
引用
收藏
页码:277 / 282
页数:6
相关论文
共 50 条
  • [1] Increased p53 protein expression in malignant mammary phyllodes tumors
    Tse, GMK
    Putti, TC
    Kung, FYL
    Scolyer, RA
    Law, BKB
    Lau, TS
    Lee, CS
    MODERN PATHOLOGY, 2002, 15 (07) : 734 - 740
  • [2] BILATERAL MALIGNANT PHYLLODES TUMORS
    BALL, ABS
    FISHER, C
    JOURNAL OF SURGICAL ONCOLOGY, 1991, 46 (01) : 67 - 69
  • [3] Increased epidermal growth factor receptor (EGFR) expression in malignant mammary phyllodes tumors
    Tse, Gary M. K.
    Lui, Philip C. W.
    Vong, Joaquim S. L.
    Lau, Kin-Mang
    Putti, Thomas C.
    Karim, Rooshdiya
    Scolyer, Richard A.
    Lee, C-Soon
    Yu, Alex M. C.
    Ng, David C. H.
    Tse, Agnes K. Y.
    Tan, Puay-Hoon
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 114 (03) : 441 - 448
  • [4] Increased epidermal growth factor receptor (EGFR) expression in malignant mammary phyllodes tumors
    Gary M. K. Tse
    Philip C. W. Lui
    Joaquim S. L. Vong
    Kin-Mang Lau
    Thomas C. Putti
    Rooshdiya Karim
    Richard A. Scolyer
    C-Soon Lee
    Alex M. C. Yu
    David C. H. Ng
    Agnes K. Y. Tse
    Puay-Hoon Tan
    Breast Cancer Research and Treatment, 2009, 114 : 441 - 448
  • [5] Increased c-kit (CD117) expression in malignant mammary phyllodes tumors
    Tse, GMK
    Putti, TC
    Lui, PCW
    Loh, AWI
    Scolyer, RA
    Law, BKB
    Karim, R
    Lee, CS
    MODERN PATHOLOGY, 2004, 17 (07) : 827 - 831
  • [6] MicroRNAs are differentially deregulated in mammary malignant phyllodes tumour
    Tsang, Julia Y. S.
    Ni, Yun-Bi
    Ng, Enders K. O.
    Shin, Vivian Y.
    Mak, Ko-Fung
    Go, Edna May L.
    Tawasil, John
    Chan, Siu-Ki
    Ko, Chun-Wai
    Kwong, Ava
    Tse, Gary M.
    HISTOPATHOLOGY, 2015, 67 (03) : 294 - 305
  • [7] Cystosarcoma phyllodes tumors.: A malignant variant
    Kastak, B
    Janulík, M
    Al-Jarallah, M
    XI INTERNATIONAL CONGRESS OF SENOLOGY, 2000, : 155 - 157
  • [8] Malignant phyllodes tumors: A review of 752 cases
    Grabowski, Julia
    Salzstein, Sidney L.
    Sadler, Georgia R.
    Blair, Sarah L.
    AMERICAN SURGEON, 2007, 73 (10) : 967 - 969
  • [9] IMAGING CHARACTERISTICS OF BENIGN AND MALIGNANT PHYLLODES TUMORS
    LIBERMAN, L
    BONACCIO, E
    HAMELEBENA, D
    ABRAMSON, AF
    COHEN, MA
    DERSHAW, DD
    RADIOLOGY, 1995, 197 : 344 - 344
  • [10] Malignant transformation of breast fibroadenoma to malignant phyllodes tumor: long-term outcome of 36 malignant phyllodes tumors
    Makoto Abe
    Satoshi Miyata
    Seiichiro Nishimura
    Kotaro Iijima
    Masujiro Makita
    Futoshi Akiyama
    Takuji Iwase
    Breast Cancer, 2011, 18 : 268 - 272